Concepedia

Andreas G. Bader

AG

33

Publications

9.7K

Citations

25

H-Index

2000

Active since

Affiliations

Mirna Therapeutics (United States)(Current)

The University of Texas MD Anderson Cancer Center

Scripps Research Institute

The University of Texas Health Science Center at San Antonio

Mayo Clinic in Arizona

Andreas G. Bader is an author at Mirna Therapeutics (United States) specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

2000–2024

33

Publications

33

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

Can Liu, Kevin Kelnar, Bigang Liu et al. · Nature Medicine · 2011 · 1.4K citations · Full text

, , +11

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors

Muhammad S. Beg, Andrew Brenner, Jasgit C. Sachdev et al. · Investigational New Drugs · 2016 · 855 citations · Full text

, , +8

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

David S. Hong, Yoon‐Koo Kang, Mitesh J. Borad et al. · British Journal of Cancer · 2020 · 850 citations · Full text

Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic

Sohye Kang, Andreas G. Bader, Peter K. Vogt · Proceedings of the National Academy of Sciences · 2005 · 821 citations · Full text

, , +16

miR-34 – a microRNA replacement therapy is headed to the clinic

Andreas G. Bader · Frontiers in Genetics · 2012 · 721 citations · Full text

, , +19

Rows per page

1–5 of 33